跳至主要内容
临床试验/DRKS00033783
DRKS00033783招募中1 期

Study on the efficiacy of an app-based intervention in patients with axial spondyloarthritis. - Bechterew-App Study 1

niversitätsklinikum Würzburg, Medizinische Klinik II, Rheumatologie/ Klinische Immunologie0 个研究点目标入组 200 人开始时间: 2024年3月1日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Clinically confirmed axSpA and regular connection to an appropriate specialist physician
  • Stable therapy situation
  • BASDAI score of = 3.5 in the screening questionnaire
  • Referring to the past 4 weeks on average:
  • Maximum of 4 times per week independent execution of axSpA-specific exercises at home, totaling a maximum of 50 minutes per week
  • Maximum of 3 times per week regular participation in sports (including strength training, endurance sports, team sports, yoga, pilates, and other sports), group gymnastics, or functional training, totaling a maximum of 90 minutes.
  • Referring to the last 3 months before study enrollment, on average, a maximum of 1 session per week of individual physiotherapy with no planned increase during the study
  • Sufficient proficiency in the German language
  • Ownership of an Android or iOS-compatible smartphone with mobile internet access, meeting the necessary requirements for using the Bechterew app
  • Adequate smartphone competence

排除标准

  • Lack of capacity to consent
  • Current pregnancy
  • Conditions that could pose a risk for increased exercise training. These include particularly advanced heart failure (NYHA 3/4), angina pectoris, severe COPD GOLD 3/4), peripheral arterial occlusive disease (pAVK) = Grade II B, obesity from Grade III onwards, active infectious diseases, acute malignant disease, status post myocardial infarction within the last 24 weeks prior to study enrollment, movement-limiting neurological diseases, acute orthopedic injury (e.g., fracture, ligament strain), status post limb amputation, ongoing or planned chemotherapy or radiation therapy (non-exhaustive list)
  • Study participant is unable to engage in daily exercise due to other health restrictions not mentioned in Chapter 8.3.2
  • Presence of an absolute contraindication to app usage as per manufacturer instructions
  • Current active use of another smartphone app for the therapy of axSpA

研究者

发起方
niversitätsklinikum Würzburg, Medizinische Klinik II, Rheumatologie/ Klinische Immunologie

相似试验